United States Biotechnology & Medical Research

Virpax Pharmaceuticals Inc (VRPX)

Track

Track

Virpax Pharmaceuticals Inc has recorded no insider trading activity within the past ninety days. The most recent transactions occurred in May 2022, when several individuals, including the Chief Executive Officer, executed purchase orders. These historical acquisitions represent the final documented movements by company personnel.
Ticker: VRPX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Sendrow Jerrold Non-Executive Director
Transaction date
Purchase
Price
425.95
Quantity 47,390 +33.1%
Value US$3,995,743
Floyd Eric Non-Executive Director
Transaction date
Purchase
Price
323.45
Quantity 52,185 +1.2%
Value US$2,915,130
Mack Anthony P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
285.84
Quantity 77,395 -25.6%
Value US$677,400
Sendrow Jerrold Non-Executive Director
Transaction date
Purchase
Price
3.93
Quantity 3,900 +643.6%
Value US$15,308
Mack Anthony P. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
3.99
Quantity 25,125 +16.6%
Value US$100,249
Jambulingam Thani Non-Executive Director
Transaction date
Purchase
Price
7.16
Quantity 100 +inf%
Value US$716
3.6
JACOB GARY S Non-Executive Director
Transaction date
Purchase
Price
6.79
Quantity 3,500 +inf%
Value US$23,762
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-26 2022-05-24 B Purchase
Sendrow Jerrold
Non-Executive Director
47,390 +33.1%
425.95
US$3,995,743 		47,390 +33.1% 425.95 US$3,995,743
2022-05-20 2022-05-18 B Purchase
Floyd Eric
Non-Executive Director
52,185 +1.2%
323.45
US$2,915,130 		52,185 +1.2% 323.45 US$2,915,130
2022-05-20 2022-05-18 B Purchase
Mack Anthony P.

Chief Executive Officer

Executive Director
77,395 -25.6%
285.84
US$677,400 		77,395 -25.6% 285.84 US$677,400
2021-11-24 2021-11-22 B Purchase
Sendrow Jerrold
Non-Executive Director
3,900 +643.6%
3.93
US$15,308 		3,900 +643.6% 3.93 US$15,308
2021-11-22 2021-11-18 B Purchase
Mack Anthony P.

Chief Executive Officer

Executive Director Large shareholder
25,125 +16.6%
3.99
US$100,249 		25,125 +16.6% 3.99 US$100,249
2021-03-01 2021-02-17 B Purchase
Jambulingam Thani
Non-Executive Director
100 +inf%
7.16
US$716 		100 +inf% 7.16 US$716
2021-02-19 2021-02-17 B Purchase
3.6
JACOB GARY S
Non-Executive Director
3,500 +inf%
6.79
US$23,762 		3,500 +inf% 6.79 US$23,762
Explore more

More insider trading research around Virpax Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America